http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-67004-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_287114022fd18ac32942a7d58b0ea658
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
filingDate 2003-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c896dd2306666c0c8fd449bb7c12c45d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeaaec2e9210a08b8327db0abe26cd97
publicationDate 2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RS-67004-A
titleOfInvention MACROCYCLIC PEPTIDES ACTIVE TO HEPATITIS C VIRUS
abstract Compounds of formula (I), wherein R 1 is a hydroxy or NHSO 2 R 1A group, wherein R 1A is (C 1-8) -alkyl, (C 3-7) -cycloalkyl or {(C 1-6) -alkyl- (C 3-7) - cycloalkyl} groups, all of which are optionally substituted with 1 to 3 halogen, cyano, nitro, O- (C1-6) -alkyl, amido, amino or phenyl groups, or R1A is a C6- or C10-aryl group , which is optionally substituted with 1 to 3 halogen, cyano, nitro, (C1-6) -alkyl, O- (C1-6) -alkyl, amido, amino or phenyl groups; R2 is (C5-6) -cycloalkyl and R3 is a cyclopentyl group; or a pharmaceutically acceptable salt thereof, useful as HCV NS3 protease inhibitors.
priorityDate 2002-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100862683
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688

Total number of triples: 37.